chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 17.0
Sex: F
Vaccine: HEPA, HPV4, MNQ
Symptoms: Neck pain, Pain in extremity, Pyrexia, Red blood cell sedimentation rate normal
Clinical narrative: Case number PHHY2012US048099 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 452066) website on 06 Jun 2012. This report refers to a 17-years-old female patient whose current condition included reflux. Her concomitant medications included omeprazole. She was vaccinated with MENVEO (batch number: A10060) and HAVRIX (other manufacturer, batch number: AHAVB549BA) intramuscularly on to right arm and GARDASIL (other manufacturer, batch number: 1560AA) intramuscularly on to left arm on 24 Feb 2012. On 29 Feb 2012, she experienced fever, back pain and neck pain. She was treated with NAPROSYN. On 12 Mar 2012, she experienced back pain, joint pain, fatigue and swollen lymph nodes on neck. Diagnostic laboratory tests were ordered on 12 Mar 2012 and Epstein-Barr virus (EBV) test, Cytomegalovirus (CMV) titer, Antinuclear antibody (ANA), C-reactive protein (CRP), Erythrocyte Sedimentation Rate (ESR), Lyme titer and Comprehensive Metabolic Panel (CMP) were done. The outcome was reported as complete recovery. All test results were reported to be normal. On 16 Mar 2012, the patient's parent reported that she experienced arm pain and numbness and rheumatologist referral was made. The outcome was reported as condition unchanged.
Age: 17.0
Sex: F
Vaccine: HEP, MMR, MNQ, TDAP
Symptoms: Rash
Clinical narrative: Case number PHHY2012US048156 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 452402) website on 06 Jun 2012. This report refers to a 17-years-old female patient whose current condition included type 1 diabetes, celiac disease and upper respiratory infection and her concomitant medications were not reported. She was vaccinated with MENVEO (batch number:X10061) and RECOMBIVAX HB (batch number: 1048NA) intramuscularly on to right arm and MMR II (batch number: 0494Z) and ADACEL (batch number: C4009BA) intramuscularly on to left arm on 23 Feb 2012. On 06 Mar 2012, she experienced rash on face, neck and torso. She went to emergency room and was treated with antihistamines (unspecified). The outcome was reported as complete recovery.
Age: 11.0
Sex: F
Vaccine: HEPA, MNQ, TDAP
Symptoms: Dizziness, Fall, Pallor
Clinical narrative: Case number PHHY2012US048171 is an initial spontaneous report received from vaccine adverse event reporting system website (reference number: 452732) on 06 Jun 2012. This case refers to an 11-year-old female patient. She was vaccinated with MENVEO (batch number: M10132) intramuscularly into her left arm on 30 Mar 2012. On the same day prior to MENVEO she was vaccinated with HVRIX ( other manufacturer, batch number: AHAVB541AA) and ADACEL (other manufacturer, batch number: U3486CA) intramuscularly into her right arm. When she was given the third vaccine MENVEO she started swaying and then fell into reporter's lap. She did not completely pass out but she was able to set up in a chair and she had lost all color. She then started falling to the side but was still alert. The outcome was reported as completely recovered. No other information was available.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Injection site erythema, Injection site swelling, Pyrexia
Clinical narrative: Case number PHHY2012US048175 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 452861) via a health care professional on 06 Jun 2012: This report refers to an 11-year-old male patient. His current illnesses included tinea corporis and his concomitant medications included LAMISIL cream. He was vaccinated with MENVEO (batch number: A11033) intramuscularly into the left arm along with tetanus, diphtheria acellular pertussis (other manufacturer and batch number: AC52B075AA) intramuscularly into the left arm on 14 Mar 2012. After vaccination he experienced a large and red swelling at the injection site on the left arm and developed a fever at 102 degree Fahrenheit. Final outcome was reported as complete recovery of the patient on an unspecified date.
Age: 23.0
Sex: F
Vaccine: MNQ
Symptoms: Anaemia, Chest discomfort, Heart rate increased
Clinical narrative: Case number PHHY2012US048179, is an initial report from the Vaccine Adverse Event Reporting System (ref: 452870) website on 06 June 2012. This report refers to 23-year-old female patient. She was vaccinated with MENVEO (batch number: M11065), in the left arm intramuscularly on 03 Apr 2012. On the same day, she experienced heavy chest and fast heartbeats. She denied having difficulty in breathing and advised to consult the physician immediately. She refused to get the medical help. She was diagnosed with anemia. The outcome of the events reported as condition unchanged at the time of reporting (03 Apr 2012). The causality of the events was not reported.
Age: 17.0
Sex: F
Vaccine: DTAPIPV, MNQ, VARCEL
Symptoms: Chest discomfort, Cough, Pyrexia
Clinical narrative: Case number PHHY2012US048132 is an initial spontaneous report received from Vaccine Adverse Event Reporting System web site (VAERS reference number: 452932) on 06 Jun 2012. This case refers to a 17-year-old female patient. Her medical history was not reported. Her concomitant medications included SOLODYN half of 115mg. She was vaccinated with KINRIX (other manufacturer, batch number: AC528073AA) and VARIVAX (other manufacturer, batch number: 1433AA). On 03 Apr 2012, she experienced tightness in chest, fever (101 F) and cough. The outcome of these events was reported as condition unchanged. No other information was available.
Age: 35.0
Sex: F
Vaccine: HEP, MMR, MNQ, PPV, TDAP
Symptoms: Chills, Erythema, Pain, Peripheral swelling, Pyrexia
Clinical narrative: Case number PHHY2012US048154 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 453140) website on 06 Jun 2012. This report refers to a 35-years-old female patient whose medical history, past drugs, current condition and concomitant medications were not reported. She was vaccinated with MENVEO (batch number: M1026A) and MMR II (other manufacturer, batch number: 0403AA) intramuscularly on to right arm and ENGERIX-B (other manufacturer, batch number: AHBVB944BB), BOOSTRIX (other manufacturer, batch number: AC52B078BA) and PNEUMOVAX (other manufacturer, batch number: 1490Z) intramuscularly on to left arm on 20 Mar 2012. On the same day, she experienced fever, chills, body aches on the night of vaccine administration to right arm. The next day she reported swelling on right arm. She applied arnica ointment to the site. On 03 Apr 2012, she experienced continuous swelling of the right arm and she went to physician. She was prescribed antibiotics. On 06 Apr 2012, she went to clinic to report the incident. It was reported that at the time of this report the right arm appears with mild redness, was tender and warm to touch and there was no drainage. The outcome of the events; fever, chills and body aches was reported as complete recovery and that of other events were not reported.
Age: 35.0
Sex: F
Vaccine: HEP, MMR, MNQ, PPV, TDAP
Symptoms: Skin warm, Tenderness
Clinical narrative: Case number PHHY2012US048154 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 453140) website on 06 Jun 2012. This report refers to a 35-years-old female patient whose medical history, past drugs, current condition and concomitant medications were not reported. She was vaccinated with MENVEO (batch number: M1026A) and MMR II (other manufacturer, batch number: 0403AA) intramuscularly on to right arm and ENGERIX-B (other manufacturer, batch number: AHBVB944BB), BOOSTRIX (other manufacturer, batch number: AC52B078BA) and PNEUMOVAX (other manufacturer, batch number: 1490Z) intramuscularly on to left arm on 20 Mar 2012. On the same day, she experienced fever, chills, body aches on the night of vaccine administration to right arm. The next day she reported swelling on right arm. She applied arnica ointment to the site. On 03 Apr 2012, she experienced continuous swelling of the right arm and she went to physician. She was prescribed antibiotics. On 06 Apr 2012, she went to clinic to report the incident. It was reported that at the time of this report the right arm appears with mild redness, was tender and warm to touch and there was no drainage. The outcome of the events; fever, chills and body aches was reported as complete recovery and that of other events were not reported.
Age: 10.0
Sex: M
Vaccine: HPV2, MNQ, TDAP
Symptoms: Erythema, Injection site erythema, Injection site swelling, Pain, Skin warm
Clinical narrative: Case number PHHY2012US056695 is an initial spontaneous report received from vaccine adverse event reporting system website (VAERS reference number: 454065) on 03 Jul 2012. This case refers to 10-year-old male patient. He has no known drug allergy. He was vaccinated with MENVEO (batch number: M10057) intramuscularly into his left arm on 16 Apr 2012. On the same day he was also vaccinated with CERVARIX (batch number: AHPVA096AD) intramuscularly into his right arm, and  ADACEL (batch number: U4137AA) intramuscularly into his right arm. Twenty four hours after vaccination the patient developed redness and swelling at the injection sites. Forty eight hours after vaccination the patient developed redness (5 1/2 x 5 1/4 inch redness) in left arm that was warm and painful to touch. He also developed two quarter size redness in right arm that was warm to touch. He had recovered completely on an unspecified date. No other information was available.
Age: 10.0
Sex: M
Vaccine: HPV2, MNQ, TDAP
Symptoms: Swelling
Clinical narrative: Case number PHHY2012US056695 is an initial spontaneous report received from vaccine adverse event reporting system website (VAERS reference number: 454065) on 03 Jul 2012. This case refers to 10-year-old male patient. He has no known drug allergy. He was vaccinated with MENVEO (batch number: M10057) intramuscularly into his left arm on 16 Apr 2012. On the same day he was also vaccinated with CERVARIX (batch number: AHPVA096AD) intramuscularly into his right arm, and  ADACEL (batch number: U4137AA) intramuscularly into his right arm. Twenty four hours after vaccination the patient developed redness and swelling at the injection sites. Forty eight hours after vaccination the patient developed redness (5 1/2 x 5 1/4 inch redness) in left arm that was warm and painful to touch. He also developed two quarter size redness in right arm that was warm to touch. He had recovered completely on an unspecified date. No other information was available.
Age: 10.0
Sex: F
Vaccine: HEPA, MNQ, TDAP
Symptoms: Drug administered at inappropriate site, No adverse event
Clinical narrative: Case number PHHY2012US056700 is an initial spontaneous report received from vaccine adverse event reporting system website (VAERS reference number: 454173) on 03 Jul 2012. This case refers to 10-year-old-female patient. She was vaccinated with MENVEO (batch number: A10132) intramuscularly into her left arm. On the same day she was concomitantly vaccinated with VAQTA (other manufacturer, and batch number: 1441AA) intramuscularly into her right arm, and BOOSTRIX (other manufacturer, batch number: AC52B078BA) intramuscularly into her right arm. Later it was identified that MENVEO was given to child only 10 years old. No adverse event was reported following vaccination. No other information was available.
Age: 18.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Erythema, Pruritus, Skin warm, Swelling
Clinical narrative: Case number PHHY2012US056714 is an initial report received from the Vaccine Adverse Event Reporting System (VAERS ref: 454323) website on 03 Jul 2012. This report refers to 18-year-old female patient. She was vaccinated MENVEO (batch number: M10133) and ADACEL (other manufacture, batch number: U4104AA) on 13 Apr 2012. On 13 Apr 2012, she experienced itchy, red, hot and swelling. The outcome of the events was reported as recovered. The causality of the events was not reported.
Age: 14.0
Sex: F
Vaccine: HPV4, MNQ
Symptoms: Peripheral swelling, Pruritus
Clinical narrative: Case number PHYY2012US056717 is an initial spontaneous report received from vaccine adverse reporting system website (reference number: 454401) on 03 Jul 2012. This case refers to a 14-year-old female patient. She was vaccinated with MEVEO (batch number: M00544) intramuscularly into her left arm on 16 Apr 2012. On the same day she was also vaccinated with GARDASIL (batch number: 1495AA) intramuscularly into her right arm. The patient's mother stated that her daughter had complaints of itching in her arm on the same day after receiving MENVEO vaccine. On an unspecified date, in the morning it was noted that the patient's arm was swollen (size of a soft ball). On an unspecified date the patient had recovered completely. No other information was available.
Age: 21.0
Sex: F
Vaccine: MNQ
Symptoms: Basophil count normal, Chills, Dizziness, Eosinophil count normal, Feeling hot
Clinical narrative: Case number PHHY2012US056737 is an initial spontaneous report received from Vaccine adverse event reporting system website (VAERS reference number: 454447) on 03 Jul 2012. This case refers to a 21-year-old female patient. Her medical history included of meningitis at the age of 9 years and dysmenorrhea. She was vaccinated with MENVEO (batch number: M11066) intramuscularly into her left arm on 24 Apr 2012. Patient awoke feeling lightheaded the day after vaccine with body aches, chills, felt warm, diaphoresis, and nausea. Two days later she felt little better but still dizzy. Laboratory data received her hemoglobin level at 13.2, hematocrit at 37.5, lymphocytes at 12, monocytes at 2, eosinophils at 2 and basophils at 1. The final outcome was reported as condition unchanged. No other information was available.
Age: 21.0
Sex: F
Vaccine: MNQ
Symptoms: Haematocrit normal, Haemoglobin normal, Hyperhidrosis, Lymphocyte count decreased, Monocyte count normal
Clinical narrative: Case number PHHY2012US056737 is an initial spontaneous report received from Vaccine adverse event reporting system website (VAERS reference number: 454447) on 03 Jul 2012. This case refers to a 21-year-old female patient. Her medical history included of meningitis at the age of 9 years and dysmenorrhea. She was vaccinated with MENVEO (batch number: M11066) intramuscularly into her left arm on 24 Apr 2012. Patient awoke feeling lightheaded the day after vaccine with body aches, chills, felt warm, diaphoresis, and nausea. Two days later she felt little better but still dizzy. Laboratory data received her hemoglobin level at 13.2, hematocrit at 37.5, lymphocytes at 12, monocytes at 2, eosinophils at 2 and basophils at 1. The final outcome was reported as condition unchanged. No other information was available.
Age: 21.0
Sex: F
Vaccine: MNQ
Symptoms: Nausea, Pain
Clinical narrative: Case number PHHY2012US056737 is an initial spontaneous report received from Vaccine adverse event reporting system website (VAERS reference number: 454447) on 03 Jul 2012. This case refers to a 21-year-old female patient. Her medical history included of meningitis at the age of 9 years and dysmenorrhea. She was vaccinated with MENVEO (batch number: M11066) intramuscularly into her left arm on 24 Apr 2012. Patient awoke feeling lightheaded the day after vaccine with body aches, chills, felt warm, diaphoresis, and nausea. Two days later she felt little better but still dizzy. Laboratory data received her hemoglobin level at 13.2, hematocrit at 37.5, lymphocytes at 12, monocytes at 2, eosinophils at 2 and basophils at 1. The final outcome was reported as condition unchanged. No other information was available.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP, MNQ
Symptoms: Injection site erythema, Injection site induration, Injection site oedema, Injection site pain, Injection site warmth
Clinical narrative: Case number PHHY2012US056740 is an initial spontaneous report received from vaccine adverse event reporting system website (VAERS reference number: 454473) on 03 Jul 2012. This case refers to a 11-year-old male patient. His concomitant medication included CLARITIN (loratadine). He was vaccinated with MENVEO (batch number: A10135) intramuscularly into his left arm on 25 Apr 2012. On the same day he was also vaccinated with BOOSTRIX (batch number: AC52B076DA) intramuscularly into his left arm. On 25 Apr 2012, he developed edema and redness (about 4x4 1/2 inch) in left upper arm at the injection site. He was afebrile but he also had complaints of tenderness with movement, mildly tender to palpation at the injection site, and slight induration and increased warmth at the injection site. He had an emergency doctor visit due to these events. He was treated with warm compression, and ibuprofen (PRN). He was advised to take non-antibiotics (BENADRYL-PRN) if not better in 24-48 hours. The final outcome was reported as condition unchanged as of 26 Apr 2012. No other information was available.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP, MNQ
Symptoms: Tenderness
Clinical narrative: Case number PHHY2012US056740 is an initial spontaneous report received from vaccine adverse event reporting system website (VAERS reference number: 454473) on 03 Jul 2012. This case refers to a 11-year-old male patient. His concomitant medication included CLARITIN (loratadine). He was vaccinated with MENVEO (batch number: A10135) intramuscularly into his left arm on 25 Apr 2012. On the same day he was also vaccinated with BOOSTRIX (batch number: AC52B076DA) intramuscularly into his left arm. On 25 Apr 2012, he developed edema and redness (about 4x4 1/2 inch) in left upper arm at the injection site. He was afebrile but he also had complaints of tenderness with movement, mildly tender to palpation at the injection site, and slight induration and increased warmth at the injection site. He had an emergency doctor visit due to these events. He was treated with warm compression, and ibuprofen (PRN). He was advised to take non-antibiotics (BENADRYL-PRN) if not better in 24-48 hours. The final outcome was reported as condition unchanged as of 26 Apr 2012. No other information was available.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP, MNQ
Symptoms: Erythema, Induration, Swelling
Clinical narrative: Case number PHHY2012US056740 is an initial spontaneous report received from vaccine adverse event reporting system website (VAERS reference number: 454473) on 03 Jul 2012. This case refers to a 11-year-old male patient. His concomitant medication included CLARITIN (loratadine). He was vaccinated with MENVEO (batch number: A10135) intramuscularly into his left arm on 25 Apr 2012. On the same day he was also vaccinated with BOOSTRIX (batch number: AC52B076DA) intramuscularly into his left arm. On 25 Apr 2012, he developed edema and redness (about 4x4 1/2 inch) in left upper arm at the injection site. He was afebrile but he also had complaints of tenderness with movement, mildly tender to palpation at the injection site, and slight induration and increased warmth at the injection site. He had an emergency doctor visit due to these events. He was treated with warm compression, and ibuprofen (PRN). He was advised to take non-antibiotics (BENADRYL-PRN) if not better in 24-48 hours. The final outcome was reported as condition unchanged as of 26 Apr 2012. No other information was available.
Age: 13.0
Sex: M
Vaccine: MNQ, TDAP, MNQ
Symptoms: Injection site erythema, Injection site induration, Injection site oedema, Injection site pain, Injection site warmth
Clinical narrative: Case number PHHY2012US056743 is an initial spontaneous report received from vaccine adverse event reporting system website (VAERS reference number: 454473) on 03 Jul 2012. This case refers to a 13-year-old male patient. His concomitant medications included VYVANSE (lisdexamfetamine dimesylate) and levetiracetam. His medical history included of attention deficit hyperactivity disorder (ADHD), epilepsy and convulsive disease. His vaccination history included of allergy to pertussis vaccine. He was vaccinated with MENVEO (batch number: M11032) intramuscularly into his right arm on 09 Apr 2012. On the same day he developed firmness, redness and swelling (site: unspecified). He had an emergency doctor visit due to these events. The final outcome was reported as condition unchanged as of 11 Apr 2012. No other information was available.
Age: 13.0
Sex: M
Vaccine: MNQ, TDAP, MNQ
Symptoms: Tenderness
Clinical narrative: Case number PHHY2012US056743 is an initial spontaneous report received from vaccine adverse event reporting system website (VAERS reference number: 454473) on 03 Jul 2012. This case refers to a 13-year-old male patient. His concomitant medications included VYVANSE (lisdexamfetamine dimesylate) and levetiracetam. His medical history included of attention deficit hyperactivity disorder (ADHD), epilepsy and convulsive disease. His vaccination history included of allergy to pertussis vaccine. He was vaccinated with MENVEO (batch number: M11032) intramuscularly into his right arm on 09 Apr 2012. On the same day he developed firmness, redness and swelling (site: unspecified). He had an emergency doctor visit due to these events. The final outcome was reported as condition unchanged as of 11 Apr 2012. No other information was available.
Age: 13.0
Sex: M
Vaccine: MNQ, TDAP, MNQ
Symptoms: Erythema, Induration, Swelling
Clinical narrative: Case number PHHY2012US056743 is an initial spontaneous report received from vaccine adverse event reporting system website (VAERS reference number: 454473) on 03 Jul 2012. This case refers to a 13-year-old male patient. His concomitant medications included VYVANSE (lisdexamfetamine dimesylate) and levetiracetam. His medical history included of attention deficit hyperactivity disorder (ADHD), epilepsy and convulsive disease. His vaccination history included of allergy to pertussis vaccine. He was vaccinated with MENVEO (batch number: M11032) intramuscularly into his right arm on 09 Apr 2012. On the same day he developed firmness, redness and swelling (site: unspecified). He had an emergency doctor visit due to these events. The final outcome was reported as condition unchanged as of 11 Apr 2012. No other information was available.
Age: 11.0
Sex: M
Vaccine: HPV4, MNQ, TDAP
Symptoms: Injection site erythema, Injection site induration, Injection site swelling
Clinical narrative: Case number PHHY2012US056752 is an initial spontaneous report received from vaccine adverse event reporting system website (VAERS reference number: 454867) on 03 Jul 2012. This case refers to a 11-year-old male patient. His preexisting condition included of rhinitis, attention deficit hyperactivity disorder (ADHD), asthma, and bipolar. His current illness included of cough and insect bite. This poly medicated patient was vaccinated with MENVEO (Batch number: A10054) into his left arm on 01 May 2012. On the same day he was vaccinated with GARDASIL (batch number: 1495AA) into his right arm, and BOOSTRIX (batch number: AC52B0745CA) into his left arm. He awoke in the morning of 02 May 2012 and noticed redness, swelling, and induration of skin over left deltoid. The outcome of the event was reported as condition unchanged as of 02 May 2012. No other information was available.
Age: 11.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Erythema, Skin warm, Swelling
Clinical narrative: Case number PHHY2012US056575 is an initial report received from the Vaccine Adverse Event Reporting System (VAERS ref: 455000) website on 03 Jul 2012. This report refers to 11-year-old female patient. She was vaccinated MENVEO (batch number: A11053), in the right arm and BOOSTRIX (other manufacture, batch number: AC52B078BA) in the left arm on 27 Apr 2012. On 28 Apr 2012, she experienced three-inch by three-inch red, slightly raised, round, warm to touch without induration. Her parents were observed for three-days and the events were worsening. The outcome of the events was reported as condition unchanged as of 30 Apr 2012. The causality of the events was not reported.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Skin lesion
Clinical narrative: Case number PHHY2012US056577 is an initial report received from the Vaccine Adverse Event Reporting System (VAERS ref: 455007) website on 03 Jul 2012. This report refers to 11-year-old male patient. He was vaccinated MENVEO (batch number: A10133), intramuscularly in the left arm and VARIVAX (other manufacture, batch number: 1248AA) subcutaneously in the left arm and ADACEL (other manufacture, batch number: U4046AB) intramuscularly in the right arm on 02 May 2012. On 03 May 2012, he experienced red, raised spot at area of vaccine (site unknown) and denied pruritus and pain. He reflected three-cm round lesion at site of vaccine (site unknown) and advised to monitor. The outcome of the events was reported as recovered. The causality of the event was not reported.
Age: 26.0
Sex: F
Vaccine: MNQ
Symptoms: Headache, Nausea, Vomiting
Clinical narrative: Case number PHHY2012US056588 is an initial report received from the Vaccine Adverse Event Reporting System (VAERS ref: 455102) web site on 03 Jul 2012. This report refers to 26-year-old female patient. She was vaccinated MENVEO (batch number: M10127B), intramuscularly in the left arm 01 May 2012. On the same day after vaccination, she experienced vomiting, headache and nausea. The outcome of the events was reported as condition unchanged as of 07 May 2012. The causality of the event was not reported.
Age: 24.0
Sex: F
Vaccine: MNQ
Symptoms: Erythema, Pain in extremity, Peripheral swelling
Clinical narrative: Case number PHHY2012US056589 is an initial spontaneous report received from Vaccine Adverse Event Reporting System web site (VAERS reference number: 455177) on 03 Jul 2012. This case refers to a 24-year-old female patient whose current condition included allergy to Penicillin. Her concomitant medications were not reported. She was vaccinated with MENVEO (batch number: M11041) through unspecified route on to left arm on 04 May 2012. On 05 May 2012 she complained of soreness in the left arm which continued for the next 2 days. On 07 May 2012, her arm was red and swollen and there was no itching. The final outcome of the event was reported as condition unchanged as of 07 May 2012.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Headache, Vomiting
Clinical narrative: Case number PHHY2012US076883, is an initial report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 455320) website on 05 Sep 2012. This report refers to 11-years-old male patient. His medical history was not reported. He was vaccinated with MENVEO (batch number: A10126), in the left arm and BOOSTRIX vaccine (other manufacturer, batch number: AC52B065AA, Dtap), in the right arm on 07 May 2012. Thirty-minutes after vaccination, he experienced headache and vomiting for four-times. The outcome of the events was reported as recovered. The causality of the events was not reported.
Age: 11.0
Sex: M
Vaccine: HPV4, MNQ, TDAP
Symptoms: Abdominal pain, Musculoskeletal stiffness, Pain, Vomiting
Clinical narrative: Case number PHHY2012US056592 is an initial spontaneous report received from vaccine adverse event reporting system website (VAERS reference number: 455398) on 03 Jul 2012. This case refers to an 11-year-old male patient whose medical history, past drugs, current conditions and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: M10047) and GARDASIL (batch number: 1537AA) intramuscularly on to left arm and ADACEL (batch number: U3874BA) intramuscularly on to right arm on 10 May 2012. On 11 May 2012, he complained of vomiting, severe headache, body aches, body stiffness and abdominal cramping. He went to emergency room. The final outcome of the event was reported as condition unchanged as of 11 May 2012.
Age: 9.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: Case number PHHY2012US067212, is an initial spontaneous report received from the vaccine adverse event reporting system (VAERS reference number: 455494) web site on 06 Aug 2012. This report refers to a 09-year-old female patient. Medical history was not provided. She was vaccinated with MENVEO (batch number: AM10133) injection, in left arm and BOOSTRIX (batch number: AC52B078BA) injection, in left arm on 03 May 2012. On 04 May 2012, she developed erythema below injection site left deltoid and was warm to touch. The outcome was reported as condition unchanged as of 05 May 2012. Seriousness and causality were not reported.
Age: 17.0
Sex: F
Vaccine: MNQ
Symptoms: Flushing, Nausea, Vomiting
Clinical narrative: Case number PHHY2012US076884, is an initial report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 455619) web site on 05 Sep 2012. This report refers to 17-years-old female patient. She felt nauseous and bloated before appointment. She was vaccinated with MENVEO (batch number: A11066), in the right arm intramuscularly on 14 May 2012. After vaccination, she stood up to leave and then she suddenly felt flushed, nauseous and vomited once. The blood pressure was measured as 100/60. She was laid down for 20 minutes and felt better. The blood pressure was measured again as 102/64 and released to go home. The outcome of the events was reported as recovered. The causality of the events was not reported.
Age: 13.0
Sex: M
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Erythema, Local swelling, Vomiting
Clinical narrative: Case number PHHY2012US067242 is an initial spontaneous report received from Vaccine Adverse Event Reporting System web site (VAERS reference number: 455659) on 06 Aug 2012. This case refers to a 13-year-old male patient. His medical history was not reported. His concomitant medications included of STRATTERA. He was vaccinated with MENVEO intramuscularly into his right arm on 24 Apr 2012. On the same day he was also vaccinated with BOOSTRIX (other manufacturer, batch number: AC52B074AA) intramuscularly into his left arm, and VARIVAX (other manufacturer, batch number: 1210AA) subcutaneously into his right arm. On 25 Apr 2012, he developed local reactions of redness and swelling, and he also had vomiting. The outcome was reported as completely recovered. Causality was not reported.
Age: 18.0
Sex: M
Vaccine: MNQ
Symptoms: Headache, Nausea, Vomiting
Clinical narrative: Case number PHHY2012US067247 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 455674) web site on 06 Aug 2012. This report refers to an 18-year-old male patient. His current conditions included environmental allergies and concomitant medications were ZYRTEC and fluticasone nasal spray. He was vaccinated with MENVEO (batch number: M10051) intramuscularly on to left arm on 16 May 2012. On the same day he experienced headache, nausea and vomiting. The outcome of the events was reported as condition unchanged as of 16 May 2012.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Case number PHHY2012US067266 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 455779) web site on 06 Aug 2012. This report refers to an 11-year-old male patient. His medical history, past drugs, current conditions and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: A11071) intramuscularly on to the deltoid of right arm on 15 May 2012. On 17 May 2012, he was seen with 12cm x 14cm red warm swollen area at the vaccination site. There was no discharge. He reported that the vaccination site area was slightly itchy. He went to emergency room. The outcome of the events was reported as condition unchanged as of 17 May 2012.
Age: 18.0
Sex: F
Vaccine: HEPA, MNQ
Symptoms: Hyperaesthesia, Pain of skin, Pyrexia
Clinical narrative: Case number PHHY2012US067273 is an initial spontaneous report received from Vaccine Adverse Event Reporting System web site (VAERS reference number: 455850) on 06 Aug 2012. This case refers to an 18-year-old female patient. Her medical history was not reported. Her concomitant medications included of SYNTHROID 0.25 mcg. She was vaccinated with MENVEO vaccine (batch number: unknown) by unspecified route on 17 May 2012. On the same day she was also vaccinated with hepatitis A vaccine (manufacturer and batch number: unknown) by unspecified route. On 17 May 2012, after vaccination the patient experienced high fever, extreme pain/sensitivity to touching of the skin, especially legs. The final outcome was reported completely recovered on an unspecified date. Causality and seriousness was not reported. No other information was available.
Age: 22.0
Sex: F
Vaccine: MNQ
Symptoms: Injection site inflammation, Injection site pruritus
Clinical narrative: Case number PHHY2012US067281 is an initial spontaneous report received from Vaccine Adverse Event Reporting System web site (VAERS reference number: 456010) on 06 Aug 2012. This case refers to a 22-year-old female patient. Her medical history included of asthma and allergy to CECLOR. She was vaccinated with MENVEO vaccine (batch number: X11041) intramuscularly into her right arm on 15 May 2012. She developed large round, inflamed, itchy area around injection site gradually appearing after injection on 16 May 2012. She was instructed to try BENADRYL 25 mg. As of 22 May 2012, she had not recovered from the events. Causality and seriousness was not reported. No other information was available.
Age: 12.0
Sex: M
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Axillary pain, Erythema, Headache, Injection site erythema, Injection site pain
Clinical narrative: Case number PHHY2012US067288 is an initial spontaneous report received from vaccine adverse event reporting system website (VAERS reference number: 456189) on 06 Aug 2012. This case refers to a 12-year-old male patient. His father stated that the patient had no allergies or history of medical problems. He was vaccinated with MENVEO vaccine (batch number: 1630AA) intramuscularly into his right arm on 22 May 2012. On the same day he was also vaccinated with BOOSTRIX (batch number: AC52B078BA) intramuscularly into his left arm, and VARIVAX vaccine (batch number: M10133) subcutaneously into his right arm. On 24 May 2012, he complained of pain, swelling and redness in right arm. He was seen by a nurse. The area of redness in right deltoid was three inches in diameter with center darker red area about one inch in diameter. He also complained of headache, pain in area of redness and right axilla. He had no fever and his temperature was at 98.5 F. He was advised to see MD if area of redness increases, pain increases, or fever 101 degrees or elevates. The outcome was reported as condition unchanged as of 24 May 2012. Causality and seriousness was not reported. No other information was available.
Age: 12.0
Sex: M
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Pain in extremity, Peripheral swelling
Clinical narrative: Case number PHHY2012US067288 is an initial spontaneous report received from vaccine adverse event reporting system website (VAERS reference number: 456189) on 06 Aug 2012. This case refers to a 12-year-old male patient. His father stated that the patient had no allergies or history of medical problems. He was vaccinated with MENVEO vaccine (batch number: 1630AA) intramuscularly into his right arm on 22 May 2012. On the same day he was also vaccinated with BOOSTRIX (batch number: AC52B078BA) intramuscularly into his left arm, and VARIVAX vaccine (batch number: M10133) subcutaneously into his right arm. On 24 May 2012, he complained of pain, swelling and redness in right arm. He was seen by a nurse. The area of redness in right deltoid was three inches in diameter with center darker red area about one inch in diameter. He also complained of headache, pain in area of redness and right axilla. He had no fever and his temperature was at 98.5 F. He was advised to see MD if area of redness increases, pain increases, or fever 101 degrees or elevates. The outcome was reported as condition unchanged as of 24 May 2012. Causality and seriousness was not reported. No other information was available.
Age: 11.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Erythema, Peripheral swelling, Skin warm
Clinical narrative: Case number PHHY2012US067290 is an initial spontaneous report received from Vaccine Adverse Event Reporting System web site(VAERS reference number: 456309) on 06 Aug 2012. This case refers to an 11-year-old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with MENVEO vaccine (batch number: M11065) intramuscularly into her left arm on 21 May 2012. On the same day she was also vaccinated with GARDASIL vaccine (batch number: 1317AA) intramuscularly into her left arm, and BOOSRIX (batch number: AC52B076BA) intramuscularly into her right arm. On 22 May 2012, her left arm swollen, red and warm to touch. Her mother gave MOTRIN orally on the same day. She went to school on 23 May 2012 but she was sent back to home by school nurse. The outcome was reported as condition unchanged as of 23 May 2012. Causality and seriousness was not reported. No other information was available.
Age: 12.0
Sex: F
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site induration, Injection site pruritus, Injection site warmth
Clinical narrative: Case number PHHY2012US067293 is an initial spontaneous report received from vaccine adverse event reporting system (VAERS reference number: 456419) web site on 06 Aug 2012. This report refers to a 12-year-old female patient. Her current condition included penicillin allergy and concomitant medications were not reported. She was vaccinated with MENVEO (batch number: M10126A) intramuscularly on to right arm on 17 May 2012. On 18 May 2012, she complained that her mid right arm through shoulder was red, hard, very itchy and hot to touch. On 21 May 2012, the events slowly got better, but were still itchy and pink. The final outcome of the events was reported as complete recovery.
Age: 1.1
Sex: F
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Erythema, Peripheral swelling, Rash, Urticaria
Clinical narrative: Case number PHHY2012US067296 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 456437) website on 06 Aug 2012. This report refers to a 1.1 year-old-female patient. Her medical history, past drugs, current condition and concomitant medications were not reported. She was vaccinated with MENVEO (batch number: X10132) through unspecified route on to right arm, ADACEL (other manufacturer, batch number: C3517BA) through unspecified route on to left arm and VARIVAX (other manufacturer, batch number: 1378AA) subcutaneously on to left arm on 18 May 2012. The patient started experiencing symptoms on 19 May 2012 and it was reported that her left arm was red and swollen with rash on 20 May 2012. Her mother reported that her right arm was also red and swollen and had half dollar size whelp. She was taken to emergency room on 20 May 2012. The final outcome of the events was reported as condition unchanged as of 22 May 2012.
Age: 17.0
Sex: F
Vaccine: MNQ
Symptoms: Headache, Neck pain
Clinical narrative: Case number PHHY2012US067302, is an initial spontaneous report received from vaccine adverse event reporting system (VAERS reference number: 456513) web site on 06 Aug 2012. This report refers to a 17-year-old female patient. Her medical history and concomitant medications were not provided. She was vaccinated with MENVEO (batch number: M11066) intramuscularly on left arm on 23 May 2012. This patient experienced headache and neck pain on 24 May 2012. The outcome of the events was reported as completely recovered. Seriousness and causality were not reported.
Age: 15.0
Sex: F
Vaccine: MNQ
Symptoms: Body temperature, Headache, Injection site erythema, Injection site induration, Neck pain
Clinical narrative: Case number PHHY2012US067303, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 456521) web site on 06 Aug 2012. This report refers to a 15-year-old female patient. Her medical history and concomitant medications were not provided. She was vaccinated with MENVEO (batch number: M11066) intramuscularly in right arm on 23 May 2012. On 24 May 2012, the patient reported of hardening and redness at injection site along with mild swelling in right forearm. She also reported that she feel like her temperature was running but she denied of checking the temperature. She also experienced headache and neck pain on 24 May 2012. The outcome of the events was reported as completely recovered. Seriousness and causality were not reported.
Age: 15.0
Sex: F
Vaccine: MNQ
Symptoms: Peripheral swelling
Clinical narrative: Case number PHHY2012US067303, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 456521) web site on 06 Aug 2012. This report refers to a 15-year-old female patient. Her medical history and concomitant medications were not provided. She was vaccinated with MENVEO (batch number: M11066) intramuscularly in right arm on 23 May 2012. On 24 May 2012, the patient reported of hardening and redness at injection site along with mild swelling in right forearm. She also reported that she feel like her temperature was running but she denied of checking the temperature. She also experienced headache and neck pain on 24 May 2012. The outcome of the events was reported as completely recovered. Seriousness and causality were not reported.
Age: 18.0
Sex: F
Vaccine: MNQ
Symptoms: Dry skin, Injection site erythema, Injection site pruritus, Injection site swelling, Skin warm
Clinical narrative: Case number PHHY2012US067305, is an initial spontaneous report received from vaccine adverse event reporting system (VAERS reference number: 456577) web site on 06 Aug 2012. This report refers to an 18-year-old female patient. Her medical history and concomitant medications were not provided. She was vaccinated with MENVEO (batch number: NOVA10051) intramuscularly in right arm on 29 May 2012. On 31 May 2012, the patient noticed swelling and redness at the site of injection, which continued to increase in size and the area was itchy. She had no fevers, in addition skin was warm and dry. The outcome was reported as condition unchanged as of 31 May 2012. Seriousness and causality were not reported.
Age: 16.0
Sex: M
Vaccine: MNQ
Symptoms: Dizziness
Clinical narrative: Case number PHHY2012US067310 is an initial spontaneous report received from a health care professional via Vaccine Adverse Event Reporting System (VAERS reference number: 456589) on 06 Aug 2012. This report refers to a 16-year-old male patient. He was vaccinated with MENVEO (batch number: M11032) intramuscularly on 12 May 2012. About five minutes after vaccination, he felt dizzy and almost fainted. He was made to sit up and made to engage in conversation for five to ten minutes. He insisted he was okay. Final outcome was reported as complete recovery of the patient.
Age: 18.0
Sex: M
Vaccine: HPV4, MNQ
Symptoms: Arthralgia, Asthenia, Body temperature increased, Chills, Myalgia
Clinical narrative: Case number PHHY2012US067319, is an initial spontaneous report received from vaccine adverse event reporting system (VAERS reference number: 456618) web site on 06 Aug 2012. This report refers to an 18-year-old male patient. The patient had no known allergies, birth defects and any medical conditions. Concomitant medications were not reported. On 19 May 2012, he was vaccinated with MENVEO (batch number: A11071), unknown route, in right arm and also with GARDASIL (batch number: 031AC) unknown route in left arm. The patient developed symptoms a few hours after immunizations. He experienced elevated temperature 99.6, chills, aches, complaints of joints hurting, sore muscles, hands and knuckles hurt and weakness. No treatment was given and he was kept under observation. The final outcome of the events was complete recovery. Seriousness and causality of the events was not reported.
Age: 18.0
Sex: M
Vaccine: HPV4, MNQ
Symptoms: Pain, Pain in extremity
Clinical narrative: Case number PHHY2012US067319, is an initial spontaneous report received from vaccine adverse event reporting system (VAERS reference number: 456618) web site on 06 Aug 2012. This report refers to an 18-year-old male patient. The patient had no known allergies, birth defects and any medical conditions. Concomitant medications were not reported. On 19 May 2012, he was vaccinated with MENVEO (batch number: A11071), unknown route, in right arm and also with GARDASIL (batch number: 031AC) unknown route in left arm. The patient developed symptoms a few hours after immunizations. He experienced elevated temperature 99.6, chills, aches, complaints of joints hurting, sore muscles, hands and knuckles hurt and weakness. No treatment was given and he was kept under observation. The final outcome of the events was complete recovery. Seriousness and causality of the events was not reported.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Haematuria, Pain in extremity, Red blood cell sedimentation rate increased
Clinical narrative: Case number PHHY2012US067320, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 456619) web site on 06 Aug 2012. This report refers to an 11-year-old male patient. He was vaccinated with MENVEO (batch number: unknown) unspecified route and site of application. The patient experienced painful lower extremity joints, knee lumbar bilateral, 14 days after MENVEO administration. There was no joint inflammation, no atrial fibrillation (AF) and rash. Lab data reported that there was no decreased complement factor (C3 or C4). Microscopic hematuria was reported and erythrocyte sedimentation rate (ESR) was 36 (unknown units). The outcome of the events was completely recovered. Seriousness and causality of the events was not reported.
Age: 39.0
Sex: F
Vaccine: MNQ
Symptoms: Abdominal discomfort, Peripheral swelling, Swelling
Clinical narrative: Case number PHHY2012US067324, is an initial spontaneous report received from vaccine adverse event reporting system (VAERS reference number: 456636) web site on 06 Aug 2012. This report refers to a 39-year-old female patient. Her medical history and concomitant medications were not reported. The patients vaccination history included Hepatitis A vaccine (unknown manufacturer, batch number: unknown) on 15 May 2012, after which she experienced gastric upset. She was vaccinated with MENVEO (batch number: M10126A) intramuscularly in left arm on 22 May 2012. The patient reported that her left arm, crown of her head, and left leg swelled on 23 May 2012. The final outcome of the events was complete recovery. Seriousness and causality of the events was not reported.
Age: 11.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Vaccination site erythema, Vaccination site induration
Clinical narrative: Case number PHHY2012US067353, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 457139) web site on 06 Aug 2012. This report refers to an 11-year-old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with MENVEO (batch number: M11065) intramuscularly in right arm and also was vaccinated with BOOSTRIX (batch number: AC526074AA) intramuscularly in left arm on 01 Jun 2012. On 03 Jun 2012, she noticed large area of erythema and induration from both vaccine sites right and left arms to elbow. She had no difficulty with respiration or ill feeling. The outcome of the events was complete recovery. Seriousness and causality of the events was not reported.
Age: 27.0
Sex: M
Vaccine: MNQ
Symptoms: Arthralgia, Asthenia, Myalgia, Pain
Clinical narrative: Case number is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS Ref: 457204) website on 06 Aug 2012: This case refers to a 27 year old male patient. He was vaccinated with MENVEO (batch number: unknown) in the left arm on 04 Jun 2012. The patient experienced severe joint and muscle pains all over the body and could not get out of bed on 11 Jun 2012. The patient visited emergency room (ER) due to the events. The outcome was reported as "not yet recovered" as of 11 Jun 2012.